Cyclin D1, retinoblastoma, p53, and Her2/neu protein expression in preinvasive breast pathologies: Correlation with vascularity

被引:13
作者
Heffelfinger, SC
Yassin, RW
Miller, MA
Lower, EE
机构
[1] Univ Cincinnati, Dept Pathol & Lab Med, Cincinnati, OH 45267 USA
[2] Univ Cincinnati, Dept Internal Med, Cincinnati, OH 45267 USA
关键词
breast cancer; angiogenesis; Her2/neu; cyclin D1; retinoblastoma; p53;
D O I
10.1159/000055913
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Objectives: Preinvasive breast pathologies show a degree of vascularization that correlates with risk of invasion. Recently, numerous oncogenes and tumor suppressor genes have been shown to regulate neovascularization. Therefore, we examined archival tissues of preinvasive breast pathologies by immunohistochemistry for alterations in the expression of four proteins, cyclin D1, retinoblastoma (Rb), p53, and Her2/neu, known to be important in breast tumorgenesis, and correlated these data with tissue vascularity. Methods: Vascularity was determined by immunologic detection of von Willebrand factor. For carcinoma in situ (CIS) both stromal vascularity (MVD) and vascular cuffing (MCD) were determined. Results: We found that cyclin D1 expression was increased in usual hyperplasia (11% of cases). Atypical hyperplasia, noncomedo CIS and comedo CIS were positive in 43, 49, and 57% of cases, respectively. Changes in Rb and p53 were rare in hyperplasia but occurred in 8 and 10% of CIS, respectively. Her2/neu protein was identified rarely in atypical hyperplasia and in both noncomedo and comedo ductal CIS. Neither Rb nor Her2/neu expression correlated with vascularity. p53 immunoreactivity correlated positively with both MCD and MVD. Cyclin D1 was negatively associated with MVD. Conclusion: These data suggest that p53 and cyclin D1 proteins may regulate the microvessel density of preinvasive breast pathologies. Copyright (C) 2001 S. Karger AG, Basel.
引用
收藏
页码:129 / 136
页数:8
相关论文
共 30 条
  • [1] Alle KM, 1998, CLIN CANCER RES, V4, P847
  • [2] Barbareschi M, 1996, APPL IMMUNOHISTOCHEM, V4, P106
  • [3] Bouvet M, 1998, CANCER RES, V58, P2288
  • [4] Buerger H, 1999, J PATHOL, V189, P521, DOI 10.1002/(SICI)1096-9896(199912)189:4<521::AID-PATH472>3.0.CO
  • [5] 2-B
  • [6] CHROMOSOME-ABNORMALITIES IN BENIGN HYPERPROLIFERATIVE DISORDERS OF EPITHELIAL AND STROMAL BREAST-TISSUE
    DIETRICH, CU
    PANDIS, N
    TEIXEIRA, MR
    BARDI, G
    GERDES, AM
    ANDERSEN, JA
    HEIM, S
    [J]. INTERNATIONAL JOURNAL OF CANCER, 1995, 60 (01) : 49 - 53
  • [7] DOGLIONI C, 1995, SURG PATHOL, V6, P129
  • [8] INDUCTION OF ANGIOGENESIS DURING THE TRANSITION FROM HYPERPLASIA TO NEOPLASIA
    FOLKMAN, J
    WATSON, K
    INGBER, D
    HANAHAN, D
    [J]. NATURE, 1989, 339 (6219) : 58 - 61
  • [9] Gillett CE, 1998, J PATHOL, V184, P396
  • [10] Mutant p53 correlates with reduced expression of thrombospondin-1, increased angiogenesis, and metastatic progression in melanoma
    Grant, SW
    Kyshtoobayeva, AS
    Kurosaki, T
    Jakowatz, J
    Fruehauf, JP
    [J]. CANCER DETECTION AND PREVENTION, 1998, 22 (03): : 185 - 194